(Q36959680)

17 August 2017

1 reference

title

Exploiting dendritic cells for active immunotherapy of cancer and chronic infections (English)

1 reference

17 August 2017

1 reference

1 reference

2

Nina Bhardwaj

1 reference

17 August 2017

David W O'Neill

1

1 reference

17 August 2017

language of work or name

1 reference

1 June 2007

1 reference

17 August 2017

published in

Molecular Biotechnology

1 reference

17 August 2017

volume

36

1 reference

17 August 2017

issue

2

1 reference

17 August 2017

page(s)

131-141

1 reference

Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo

17 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12033-007-0020-6

Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12033-007-0020-6

Scavenger receptors in innate immunity

21 January 2018

1 reference

12 December 2020

C-type lectin receptors on dendritic cells and Langerhans cells

1 reference

12 December 2020

A fresh look at tumor immunosurveillance and immunotherapy.

1 reference

12 December 2020

Linking innate and adaptive immunity

1 reference

12 December 2020

Dendritic cells: specialized and regulated antigen processing machines

1 reference

12 December 2020

Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells.

1 reference

12 December 2020

Immunology. CD8 T cells remember with a little help

1 reference

12 December 2020

Toll-like receptors in the induction of the innate immune response

1 reference

12 December 2020

How dendritic cells and microbes interact to elicit or subvert protective immune responses

1 reference

12 December 2020

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

12 December 2020

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

1 reference

12 December 2020

Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine

1 reference

12 December 2020

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

1 reference

12 December 2020

CTLA-4 blockade: unveiling immune regulation

1 reference

12 December 2020

Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12

1 reference

12 December 2020

Processing and presentation of antigens by dendritic cells: implications for vaccines

1 reference

12 December 2020

Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels

1 reference

12 December 2020

Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells.

1 reference

12 December 2020

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application

1 reference

12 December 2020

A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy

1 reference

12 December 2020

Dendritic cells: immunobiology and cancer immunotherapy.

1 reference

12 December 2020

Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide.

1 reference

12 December 2020

1 reference

12 December 2020

Toll-like receptors and innate immunity

1 reference

12 December 2020

Interleukin-12 and the regulation of innate resistance and adaptive immunity

1 reference

12 December 2020

Viral vectors for dendritic cell-based immunotherapy

1 reference

12 December 2020

Tumor vaccines: a role in preventing recurrence in melanoma?

1 reference

12 December 2020

Antigen processing and recognition

1 reference

12 December 2020

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

1 reference

12 December 2020

Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes

1 reference

12 December 2020

Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells

1 reference

12 December 2020

Chemokines: agents for the immunotherapy of cancer?

1 reference

12 December 2020

Exploiting dendritic cells to improve vaccine efficacy

1 reference

12 December 2020

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

1 reference

12 December 2020

A blast from the past: clearance of apoptotic cells regulates immune responses.

1 reference

12 December 2020

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

1 reference

12 December 2020

A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer.

1 reference

12 December 2020

Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses.

1 reference

12 December 2020

Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity.

1 reference

12 December 2020

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

1 reference

12 December 2020

Vaccines and melanoma

1 reference

12 December 2020

Cross-presentation in viral immunity and self-tolerance.

1 reference

12 December 2020

Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors

1 reference

12 December 2020

Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?

1 reference

12 December 2020

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

12 December 2020

Induction of antitumor immunity using bone marrow-generated dendritic cells

1 reference

12 December 2020

Human dendritic Langerhans cells generated in vitro from CD34+ progenitors can prime naive CD4+ T cells and process soluble antigen.

1 reference

12 December 2020

Peptide-based cancer vaccines

1 reference

12 December 2020

Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells

1 reference

12 December 2020

Identification of tumour-associated T-cell epitopes for vaccine development

1 reference

12 December 2020

Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells

1 reference

12 December 2020

T cell priming by dendritic cells: thresholds for proliferation, differentiation and death and intraclonal functional diversification

1 reference

12 December 2020

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

1 reference

12 December 2020

From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation

1 reference

12 December 2020

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

1 reference

12 December 2020

Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance

1 reference

12 December 2020

Understanding the generation and function of memory T cell subsets

1 reference

12 December 2020

Intracellular pathways of CD1 antigen presentation

1 reference

12 December 2020

Dendritic cells as vectors for therapy

1 reference

12 December 2020

Eighth Leucocyte Differentiation Antigen Workshop DC section summary.

1 reference

12 December 2020

Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation

1 reference

12 December 2020

Sipuleucel-T (APC8015) for prostate cancer

1 reference

12 December 2020

Tolerogenic dendritic cells

1 reference

12 December 2020

Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity

1 reference

12 December 2020

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

12 December 2020

Dendritic cells injected via different routes induce immunity in cancer patients

1 reference

12 December 2020

Poxviruses as vectors for cancer immunotherapy.

1 reference

12 December 2020

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

1 reference

12 December 2020

Restoring function in exhausted CD8 T cells during chronic viral infection

1 reference

12 December 2020

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.

1 reference

12 December 2020

Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients

1 reference

12 December 2020

The unfulfilled promise of melanoma vaccines

1 reference

12 December 2020

Sensing pathogens and tuning immune responses

1 reference

12 December 2020

High efficiency adenovirus-mediated gene transfer to human dendritic cells

1 reference

12 December 2020

Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo

1 reference

12 December 2020

Treatment of solid tumours in children with tumour-lysate-pulsed dendritic cells

1 reference

12 December 2020

Towards an understanding of the transcription factor network of dendritic cell development

1 reference

12 December 2020

Dendritic cells are potent antigen-presenting cells for microbial superantigens

1 reference

12 December 2020

IFN-α-conditioned dendritic cells are highly efficient in inducing cross-priming CD8+ T cells against exogenous viral antigens

1 reference

12 December 2020

Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity

1 reference

12 December 2020

Progress on new vaccine strategies against chronic viral infections

1 reference

12 December 2020

Recognition of tumor glycans by antigen-presenting cells

1 reference

12 December 2020

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

1 reference

12 December 2020

Cancer Tumor antigens

1 reference

12 December 2020

Immunity against cancer: lessons learned from melanoma.

1 reference

12 December 2020

Characterization of human blood dendritic cell subsets

1 reference

12 December 2020

Immune complex-mediated antigen presentation induces tumor immunity

1 reference

12 December 2020

Cross-presentation: underlying mechanisms and role in immune surveillance

1 reference

12 December 2020

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

12 December 2020

The unconventional lifestyle of NKT cells

1 reference

12 December 2020

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

1 reference

12 December 2020

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

1 reference

12 December 2020

Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells

1 reference

12 December 2020

Therapeutic cancer vaccines

1 reference

12 December 2020

Characterization of a common precursor population for dendritic cells

1 reference

12 December 2020

1 reference

12 December 2020

Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection

1 reference

12 December 2020

Principles and use of anti-CTLA4 antibody in human cancer immunotherapy

1 reference

12 December 2020

Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.

1 reference

12 December 2020

Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells

1 reference

12 December 2020

Molecular identification of a danger signal that alerts the immune system to dying cells

1 reference

12 December 2020

Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer

1 reference

12 December 2020

Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.

1 reference

12 December 2020

Cancer vaccine field gets shot of optimism from positive results.

1 reference

12 December 2020

Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells

1 reference

12 December 2020

Adjuvant therapy for patients with high-risk malignant melanoma

1 reference

12 December 2020

Development of thymic and splenic dendritic cell populations from different hemopoietic precursors.

1 reference

12 December 2020

Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates

1 reference

12 December 2020

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

1 reference

12 December 2020

Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions

1 reference

12 December 2020

Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.

1 reference

12 December 2020

Immunobiology of dendritic cells

1 reference

12 December 2020

Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade

1 reference

12 December 2020

T cell fitness determined by signal strength

1 reference

12 December 2020

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

1 reference

12 December 2020

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

1 reference

12 December 2020

Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity

1 reference

12 December 2020

Clinical translation of angiogenesis inhibitors

1 reference

12 December 2020

Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals

1 reference

12 December 2020

The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids

1 reference

12 December 2020

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6

1 reference

12 December 2020

Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

1 reference

12 December 2020

The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3

1 reference

12 December 2020

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

1 reference

12 December 2020

Dendritic cell potentials of early lymphoid and myeloid progenitors

1 reference

12 December 2020

Dynamic imaging of T cell-dendritic cell interactions in lymph nodes

1 reference

12 December 2020

Generation of high quantities of viral and tumor-specific human CD4+ and CD8+ T-cell clones using peptide pulsed mature dendritic cells

1 reference

12 December 2020

Toll-like receptor 3 promotes cross-priming to virus-infected cells.

1 reference

12 December 2020

Proteasome and peptidase function in MHC-class-I-mediated antigen presentation

1 reference

12 December 2020

Immunotherapy of cancer with dendritic-cell-based vaccines

1 reference

12 December 2020

From the antigen-presenting cell to the antigen-presenting vesicle: the exosomes.

1 reference

12 December 2020

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

1 reference

12 December 2020

Induction of strong and persistent MelanA/MART-1-specific immune responses by adjuvant dendritic cell-based vaccination of stage II melanoma patients.

1 reference

12 December 2020

Danger signals: SOS to the immune system

1 reference

12 December 2020

Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells

1 reference

12 December 2020

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

1 reference

12 December 2020

Mouse and human dendritic cell subtypes

1 reference

12 December 2020

Strategies for designing and optimizing new generation vaccines

1 reference

12 December 2020

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

1 reference

12 December 2020

Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha

1 reference

12 December 2020

Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with

1 reference

12 December 2020

Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization.

1 reference

12 December 2020

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

1 reference

12 December 2020

The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics

1 reference

12 December 2020

Dendritic cells as therapeutic vaccines against cancer

1 reference

12 December 2020

Combinatorial cancer immunotherapy

1 reference

12 December 2020

Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells

1 reference

12 December 2020

Role of Toll-like receptors in costimulating cytotoxic T cell responses

1 reference

12 December 2020

Dendritic cell precursor populations of mouse blood: identification of the murine homologues of human blood plasmacytoid pre-DC2 and CD11c+ DC1 precursors

1 reference

12 December 2020

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

12 December 2020

10.1007/S12033-007-0020-6

Identifiers

DOI

1 reference

17 August 2017

1 reference